BIX01294, an inhibitor of histone methyltransferase, induces autophagy-dependent differentiation of glioma stem-like cells
Glioblastoma (GBM) contains rare glioma stem-like cells (GSCs) with capacities of self-renewal, multi-lineage differentiation, and resistance to conventional therapy. Drug-induced differentiation of GSCs is recognized as a promising approach of anti-glioma therapy. Accumulating evidence suggests tha...
Main Authors: | Ciechomska, Iwona Anna, Przanowski, Piotr, Jackl, Judyta, Wojtas, Bartosz, Kaminska, Bozena |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146656/ |
Similar Items
-
Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294
by: PANG, ALAN LAP-YIN, et al.
Published: (2014) -
The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1α Stability and Angiogenesis
by: Oh, Su Young, et al.
Published: (2015) -
Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity
by: Rotili, Dante, et al.
Published: (2014) -
Mechanism of G9a inhibitor BIX-01294 acting on U251 glioma cells
by: Guo, Ai-Shun, et al.
Published: (2016) -
The Selective Activation of p53 Target Genes Regulated by SMYD2 in BIX-01294 Induced Autophagy-Related Cell Death
by: Fan, Jia-Dong, et al.
Published: (2015)